12 results on '"HIV infection -- Drug therapy -- Patient outcomes"'
Search Results
2. New Viral Load Findings Reported from Johns Hopkins University (Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression In Postpartum Women Living With Hiv-1 From Promoting Maternal and Infant Survival ...)
3. International AIDS Society Researchers Highlight Research in Antiretrovirals (How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia)
4. Data on Viral Load Described by a Researcher at University of Montreal (Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy)
5. New Clinical Trial Research Data Have Been Reported by Researchers at University of Cape Town (Improved Virologic Outcomes In Postpartum Women Living With Hiv Referred To Differentiated Models of Care)
6. New Findings in Antiretrovirals Described from ViiV Healthcare (Pregnancy Outcomes and Pharmacokinetics In Pregnant Women Living With Hiv Exposed To Long-acting Cabotegravir and Rilpivirine In Clinical Trials)
7. San Salvatore Hospital Researcher Yields New Data on Antiretrovirals (Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV)
8. New Findings from Weill Cornell Medical College in the Area of COVID-19 Reported [Sars Cov-2 Mrna Vaccination Exposes Latent Hiv To Nef-specific Cd8(+) T-cells]
9. Researchers at World Health Organization (WHO) Target HIV/AIDS (Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance In People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-containing Antiretroviral Therapy: a ...)
10. Findings in the Area of HIV Integrase Inhibitors Reported from Epividian Inc. (Dolutegravir/rilpivirine 2-drug Regimen Comparable To Commonly Prescribed 3-drug Regimens Up To 18-months In a Real-world Setting)
11. Recent Studies from University of Paris Add New Data to Antiretrovirals (Long-term Safety and Efficacy of Rilpivirine In Combination With Nucleoside/nucleotide Reverse Transcriptase Inhibitors In Hiv-1 Infected Patients: 336-week Rollover Study ...)
12. New HIV Integrase Inhibitors Study Findings Recently Were Reported by Researchers at San Salvatore Hospital (Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.